Kazakh Scientist is Developing Drug for Cancer Treatment

Senior Researcher at the Laboratory of Bioengineering and Regenerative Medicine at NLA Bauyrzhan Umbayev told Kazinform about his scientific research aimed at developing a cancer treatment. The scientist is developing a drug intended to treat malignant tumors of the colon by reducing the activity of the CDC42 protein, which also affects aging.

Senior Researcher at the Laboratory of Bioengineering and Regenerative Medicine at NLA Bauyrzhan Umbayev told Kazinform about his scientific research aimed at developing a cancer treatment. The scientist is developing a drug intended to treat malignant tumors of the colon by reducing the activity of the CDC42 protein, which also affects aging.

Up

 © Nazarbayev University

Republic of Kazakhstan, Astana city, 53 Kabanbay Batyr Ave.